Neuroone Medical Technologies Corp Capital Reinvestment Ratio

Latest as of December 2024: 0.12x

Neuroone Medical Technologies Corp capital reinvestment ratio. Neuroone Medical Technologies Corp (NMTC) has a Capital Reinvestment Ratio of 0.12x as of December 2024, meaning it reinvests 0% of its operating cash flow ($208.05K) in capital expenditures ($24.42K). Check Neuroone Medical Technologies Corp (NMTC) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.12x

Capex / Operating Cash Flow

Operating Cash Flow

$208.05K

USD

Capital Expenditures

$24.42K

USD

Data as of

Dec 2024

Most recent filing

Neuroone Medical Technologies Corp Capital Reinvestment Ratio by Year (None–None)

Neuroone Medical Technologies Corp capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see Neuroone Medical Technologies Corp cash conversion from operations.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow